SGLT2 inhibitors ‐ the first successful treatment for HFpEF?

Petrie, M. C. , Lee, M. M.Y. and Docherty, K. F. (2021) SGLT2 inhibitors ‐ the first successful treatment for HFpEF? European Journal of Heart Failure, (doi: 10.1002/ejhf.2108) (PMID:33502794) (Early Online Publication)

[img] Text
232915.pdf - Accepted Version
Restricted to Repository staff only until 27 January 2022.

1MB

Abstract

No abstract available.

Item Type:Articles (Editorial)
Status:Early Online Publication
Refereed:Yes
Glasgow Author(s) Enlighten ID:Lee, Matthew and Docherty, Dr Kieran and Petrie, Professor Mark
Authors: Petrie, M. C., Lee, M. M.Y., and Docherty, K. F.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:European Journal of Heart Failure
Publisher:Wiley
ISSN:1388-9842
ISSN (Online):1879-0844
Published Online:27 January 2021
Copyright Holders:Copyright © 2021 European Society of Cardiology
First Published:First published in European Journal of Heart Failure 2021
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
190814BHF centre of excellenceRhian TouyzBritish Heart Foundation (BHF)RE/13/5/30177Institute of Cardiovascular & Medical Sciences
303944BHF Centre of ExcellenceRhian TouyzBritish Heart Foundation (BHF)RE/18/6/34217CAMS - Cardiovascular Science